Nightingale Health receives third regulatory approval for healthcare use from Health Sciences Authority in Singapore
Nightingale Health Plc Press release 19 September 2024 at 1:00 p.m. (EEST) Nightingale Health Plc (“Nightingale Health”), a pioneer in disease risk detection and preventative health has received a third regulatory approval from Singapore’s Health Sciences Authority (HSA), the national body that regulates medical devices, therapeutics, and other healthcare products. Nightingale Health has announced earlier this year two approvals that covered the analysis of eight common clinically used biomarkers: total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides,